Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
08/2011
08/10/2011CN102145118A Morinda officinalis wine
08/10/2011CN102145103A Traditional Chinese medicine composition for warming and invigorating kidney yang and replenishing qi to promote diuresis and preparation method thereof
08/10/2011CN102145102A Traditional Chinese medicinal composition for warming and tonifying kidney yang and strengthening qi and promoting diuresis and preparation method thereof
08/10/2011CN102145086A Plantago tonic decoction for treating chronic prostatitis
08/10/2011CN102145040A Technique for adsorbing and extracting effective part of folium orthosiphoni by employing macroporous resin
08/10/2011CN102145007A Finasteride soft capsule and amsulosin hydrochloride capsule compound preparation, used capsule and preparing method
08/10/2011CN102145003A Medicinal composition containing insoluble medicament
08/10/2011CN102144980A LHRH (luteinizing hormone-releasing hormone antagonist) lyophilized powder injection with improved stability
08/10/2011CN101974068B Tanshinon IIA crylic acid or sodium salt thereof, preparation method and application thereof
08/10/2011CN101843833B Chinese medicament for treating diabetic nephropathy
08/10/2011CN101700370B Method for preparing pharmaceutical composition for treating diseases of urinary system and method for detecting components thereof
08/10/2011CN101700367B Pharmaceutical composition for treating diseases of urinary system
08/10/2011CN101690781B Traditional Chinese medicine composite for treating chronic nephritis
08/10/2011CN101385768B Application of Loitered sheep root eluate in preparing drugs of chronic glomerulonephritis treatment
08/09/2011US7994346 such as methyl 2-({(4S,5R)-5-[(1E,3E,7E)-(S)-10-(4-fluorophenoxy)-9-hydroxydeca-1,3,7-trien-5-yn-1-yl]-2,2-dimethyl-1,3-dioxolan-4-yl}methoxy)acetate, useful in treating inflammatory and autoimmune disorders in humans
08/09/2011US7994317 sEH inhibitors and their use
08/09/2011US7994282 Card proteins involved in cell death regulation
08/09/2011US7994128 Conotoxin peptides useful as inhibitors of neuronal amine transporters
08/09/2011US7993878 Antibodies to human IL-1β
08/09/2011US7993849 Human TIMP-1 antibodies
08/09/2011US7993671 Blend of: (a) one or more polymers; and (b) a drug that is liquid ad room temperature; free of water and other low boiling liquids; pressure-sensitive transdermal drug delivery system
08/09/2011US7993643 Using low density lipoprotein receptor specific immunoglobulin for treatment and prevention of athersclerotic, kidney and inflammatory disorders
08/09/2011CA2447921C Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules
08/09/2011CA2441492C Rho-kinase inhibitors
08/09/2011CA2428039C Serotonergic agents
08/04/2011WO2011094208A2 Methods and pharmaceutical compositions for preventing and treating renal impairment
08/04/2011WO2011093826A2 Effervescent formulations comprising cefaclor and clavulanic acid as active agents
08/04/2011WO2011093825A2 Effervescent dosage forms comprising cephalosporin antibiotic
08/04/2011WO2011093824A2 Effervescent formulations comprising cefaclor
08/04/2011WO2011093823A2 Effervescent formulations comprising cefaclor and clavulanic acid
08/04/2011WO2011092187A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
08/04/2011WO2011037913A3 Methods for preventing oxidative stress injury of a tissue by a folate-tempol conjugate
08/04/2011US20110190355 Heterocyclic indazole derivatives
08/04/2011US20110190341 Substituted isoquinolines and isoquinolinones as rho kinase inhibitors
08/04/2011US20110190340 Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives
08/04/2011US20110190319 Substituted heteroaryl fused derivatives as pi3k inhibitors
08/04/2011US20110190308 Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
08/04/2011US20110190294 Novel estrogen receptor ligands
08/04/2011US20110190263 Compounds and compositions as modulators of gpr119 activity
08/04/2011US20110190256 Amine and Ether Compounds Which Modulate The CB2 Receptor
08/04/2011US20110190240 Nuclear factor kappa b pathway inhibitor composition and use of same
08/04/2011US20110189285 Hydrogel capable of containing and conveying cells
08/04/2011US20110189121 Bitablets comprising compacted polyallylamine polymer and method for the production thereof
08/04/2011US20110189082 Human gm-csf antigen binding proteins
08/04/2011CA2784571A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
08/03/2011EP2351765A2 Oligonucleotide-containing pharmacological compositions and their use
08/03/2011EP2351749A1 Carbamate compound or salt thereof
08/03/2011EP2351748A1 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient
08/03/2011EP2351742A1 Indazole derivative
08/03/2011EP2349996A1 1-phenylpyrrole compounds
08/03/2011EP2349320A1 Compositions and methods for treatment of kidney disorders
08/03/2011EP2349256A1 Heterocyclic benzimidazoles as trpm8 modulators
08/03/2011EP2349239A1 Detection and use of low molecular-weight modulators of the cold-menthol receptor trpm8
08/03/2011EP1846366B1 Norvaline derivative and method for preparation thereof
08/03/2011EP1480634B1 Selective androgen receptor modulators (SARMs) for treating benign prostate hyperplasia
08/03/2011EP1446104B2 Spray drying methods
08/03/2011CN102143956A Derivatives of indole 2-carboxamides and azaindole 2-carboxamides substituted by a silanyle group, preparation thereof and therapeutic use thereof
08/03/2011CN102143946A Calcium ion channel modulators & uses thereof
08/03/2011CN102143740A Use of opioid antagonists for treating urinary retention
08/03/2011CN102140090A Dipeptidyl peptidase inhibitors
08/03/2011CN102140081A Process for the preparation of indazolyl ureas that inhibit vanilloid subtype 1 (VR1) receptors
08/03/2011CN102140064A Compounds for the treatment of metabolic disorders
08/03/2011CN102139083A Formula of medicament for treating cholecystitis and urolithiasis
08/03/2011CN102139019A Application of camellia oleifera peel extract
08/03/2011CN102139017A Raw materials of kidney tonifying spirits, kidney tonifying spirits and preparation method of kidney tonifying spirits
08/03/2011CN102139014A Traditional Chinese medicine for treating diabetic nephropathy
08/03/2011CN102139013A Health care tonic wine for strengthening yang
08/03/2011CN102139009A Traditional Chinese medicine for treating chronic prostatitis
08/03/2011CN102139002A Cortex phellodendri polysaccharide extract and preparation method and medical application thereof
08/03/2011CN102138992A Traditional Chinese medicine for treating benign prostatic hyperplasia
08/03/2011CN102138981A Preparation method of plantago seed polysaccharide extractive and applications thereof
08/03/2011CN102138954A Quality control method of pulean preparation
08/03/2011CN102138932A Buffered compositions for dialysis
08/03/2011CN102138919A New application of sodium ferrous chlorophyll to promotion of erythropoiesis
08/03/2011CN102138900A Solid preparation of oxapium iodide liposome
08/03/2011CN101919837B Application of rosmarinic acid in preparing medicament for treating or preventing renal fibrosis
08/03/2011CN101766777B Chinese medicine composite for treating chronic renal failure
08/03/2011CN101160287B 吡啶基非芳香族含氮杂环-1-羧酸酯衍生物 Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative
08/02/2011US7989661 Human ADAM-10 inhibitors
08/02/2011US7989654 High purity bases of 3,3-diphenylpropylamino monoesters
08/02/2011US7989478 Cinnamoyl compound and use of the same
08/02/2011CA2488242C Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same
08/02/2011CA2470956C 1-alkyl-1-azoniabicyclo[2.2.2]octane carbamate derivatives and their use as muscarinic receptor antagonists
08/02/2011CA2447632C Fusion protein agonist comprising a growth hormone binding portion and an external domain of a growth hormone receptor
08/02/2011CA1341619C Recombinant inhibin
07/2011
07/28/2011WO2011090676A1 Compositions including pyruvate for companion animals and methods of use thereof
07/28/2011WO2011089173A1 Hydrogel of microspheres
07/28/2011WO2011068438A3 Agent for the treatment and prevention of diseases of the male urogenital system
07/28/2011WO2011060065A3 Instillation of liposomal formulation of sirna and antisense oligonucleotides
07/28/2011WO2010111599A3 Compositions and methods for treatment of renal disease
07/28/2011US20110184038 Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity
07/28/2011US20110184034 Severe sepsis preventive therapeutic agent
07/28/2011US20110184032 Novel Phenylamino Isonicotinamide Compounds
07/28/2011US20110184021 2-Acylaminopropoanol-Type Glucosylceramide Synthase Inhibitors
07/28/2011US20110184015 Novel derivatives of pyrroloindole which are inhibitors of hsp90, compositions containing same, and use thereof
07/28/2011US20110183997 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors
07/28/2011US20110183991 5ht7 receptor ligands and compositions comprising the same
07/28/2011US20110183986 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
07/28/2011US20110183985 Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors
07/28/2011US20110183965 6-aminoisoquinoline compounds